Project Grant R41DA060000
Award Date
9/15/24
Completion Date
8/31/25
Dollars Obligated
$592K
Federal Agency
National Institute on Drug Abuse
Awardee
Oprems LLC (SSPYRBM9X556)
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Illinois, USA
Similar Awards
The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $1,607,146 Project Grant to Ndri-Usa Inc., a non-profit organization based in New York City. The grant, titled "TOGETHER AGAINST OVERDOSE: COMMUNITY DEVELOPED TECHNOLOGY TO ENCOURAGE DRUG CHECKING, DISTRIBUTION OF HARM REDUCTION SUPPLIES, AND LINKAGE TO SERVICES", aims to develop technology-based interventions to increase protective behaviors against overdose, such...
The National Institute on Drug Abuse (NIDA) awarded a $386,452 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Electronic Biosciences, Inc., a small biotechnology company in San Diego, California. The grant supports the development of a rapid fingerstick diagnostic for opioid and stimulant use disorders (OUD/STUD), which represent a significant public health crisis with over 107,000 overdose deaths reported in 2022. The project period runs from April 1, 2025, to...
The National Institute on Drug Abuse (NIDA) awarded a $643,948 Project Grant under CFDA 93.279 (Drug Use and Addiction Research Programs) to Labsys LLC, a for-profit limited liability company located in East Lansing, Michigan. The grant, titled "Wearable Continuous Drug Monitoring Device for Personal Medications in Opioid Use Disorders (CDM-MOUD)," aims to develop a transformative wearable patch that can continuously monitor medication levels in individuals with opioid use disorders....
The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $304,023 Project Grant to Evidation Health, Inc. to develop a digital platform called "RESHAPE" that addresses health-related social needs (HRSN) impacting substance use disorder (SUD) recovery. The project aims to create a comprehensive digital experience that provides personalized education, insights, and support to improve the well-being and self-efficacy of...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is supporting the development of a software-based medical device (SAMD) for detecting opioid use through voice analysis. The $800,000 award to Tenvos Inc., a minority-owned and woman-owned technology company, aims to advance the company's AI-driven solution that can enable patients to remotely test for opioid use and securely share results with...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $854,122 to Resilient Lifescience, Inc. to develop a wearable medical device capable of detecting opioid-induced respiratory depression and issuing an emergency alert. The goal is to create a lifesaving technology that can promptly notify emergency responders and loved ones of an opioid overdose, enabling the timely administration of...
The National Institute on Drug Abuse (NIDA) awarded a $1,076,018 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Dynamicare Health Inc. in Wareham, MA. The award will fund a Phase II randomized clinical trial to evaluate the efficacy of DCH-003, a digital therapeutic that delivers contingency management for the treatment of stimulant use disorder. The trial will compare standard clinic care plus DCH-003 to standard care plus a sham digital app, with the...
The National Institute on Drug Abuse (NIDA) awarded a $326,410 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Berkshire Biomedical Corporation. The grant, which runs from June 1, 2025 to May 31, 2026, will fund a two-phased clinical study to evaluate the feasibility and efficacy of the Computerized Oral Prescription Administration System (COPA) - a hand-held, automated, personalized oral liquid dispensing system designed to deliver take-home methadone...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $598,312 to Addinex Technologies, Inc. to integrate and assess a closed-loop medication management system focused on opioid pain management for patients with extremity fractures being discharged from the emergency department. The system aims to reduce opioid use by integrating an opioid dispensing, monitoring, and disposal platform with a...
The National Institute on Drug Abuse (NIDA) awarded a $857,121 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Meaningful Measurement, Inc., a woman-owned small business. The grant aims to develop and test a prototype mobile health application called R-ASSIST to support individuals with co-occurring opioid use and mental health disorders released from jail. Key features of R-ASSIST will include daily symptom and medication monitoring, a self-help curriculum, a...